Clinical Trial Update: Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for de Novo Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cladribine plus homoharringtonine and cytarabine (CHA) for de novo acute myeloid leukemia has completed, with the update detailing tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cytosar-U (cytarabine)
• Leustatin (cladribine)
• Synribo (omacetaxine mepesuccinate)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Acute Myeloid Leukemia, Adult | Phase 2 | Status: COMPLETED